Drug resistance in yeasts - An emerging scenario

Advances in Microbial Physiology

Volumn 46, Issue , 2002, Pages 155-201

  Prasad, Rajendra ^a   Lata Panwar, Sneh ^a   Smriti, ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AMILORIDE; AMINOTRIAZOLE; AMOROLFINE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; BENOMYL; BREFELDIN A; CERULENIN; CHLORAMPHENICOL; CRYSTAL VIOLET; CYCLOHEXIMIDE; DACTINOMYCIN; ECHINOCANDIN B; ERGOSTEROL; ETHIDIUM BROMIDE; FLUCONAZOLE; FLUCYTOSINE; FLUPHENAZINE; KETOCONAZOLE; MESYLIC ACID METHYL ESTER; METHOTREXATE; MYCOPHENOLIC ACID; TERBINAFINE; TETRACENOMYCIN C; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

BINDING SITE; BIOSYNTHESIS; CANDIDA ALBICANS; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; MEMBRANE TRANSPORT; MULTIDRUG RESISTANCE; NONHUMAN; POINT MUTATION; REVIEW; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION REGULATION; YEAST; CANDIDIASIS; DRUG EFFECT; GENETICS; IMMUNE DEFICIENCY; METABOLISM; PHYSIOLOGY;

CANDIDA; CANDIDA ALBICANS; FUNGI; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE; SACCHAROMYCETALES; VIOLA (ANGIOSPERM);

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, MULTIPLE, FUNGAL; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; IMMUNOCOMPROMISED HOST; SACCHAROMYCES CEREVISIAE;

EID: 0035985631     PISSN: 00652911     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2911(02)46004-3     Document Type: Review

References (223)

1. The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans
2. AP1-mediated multidrug resistance in Saccharomyces cerevisiae requires FLR1 encoding a transporter of the major facilitator superfamily
3. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance
4. Drug-stimulatable ATPase activity in crude membranes of human MDR1-transfected mammalian cells
5. Partial purification and reconstitution of the human multidrug-resistance pump: Characterisation of the drug-stimulatable ATP hydrolysis
6. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
7. Nucleoside triphosphates are required to open the CFTR chloride channel
8. The ABC transporter AtrB from Aspergillus nidulans mediates resistance to all major classes of fungicides and some natural toxic compounds
9. The role of ABC transporters from Aspergillus nidulans in protection against cytotoxic agents and in antibiotic production
10. Expression of atrC-encoding a novel member of the ATP binding cassette transporter family in Aspergillus nidulans is sensitive to cycloheximide
11. The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter
12. Multiple or pleiotropic drug resistance in yeast
13. Genetics and biochemistry of yeast multidrug resistance
14. Yeast multidrug resistance: The PDR network
15. PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1
16. Inventory and function of yeast ABC proteins: About sex, stress, and pleiotropic drug and heavy metal resistance
17. Reduced virulence of Candida albicans mutants affected in multidrug resistance
18. Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: Pathophysiological implications
19. Lipid translocation across the plasma membrane of mammalian cells
20. Reconstitution of a bacterial periplasmic permease in proteoliposomes and demonstration of ATP hydrolysis concomitant with transport
21. Molecular cloning and expression of Saccharomyces cerevisiae STS1 gene product, a yeast ABC transporter conferring mycotoxin resistance
22. The structure and function of drug pumps
23. Novel approaches in the rational design of antifungal agents of low toxicity
24. Modeling cytochrome P450 14α-demethylase (Candida albicans) from P450cam
25. FLR1 gene (ORFYBR008c) is required for benomyl and methotrexate resistance in Saccharomyces cerevisiae and its benomyl induced expression is dependent on Pdr3 transcriptional regulator
26. Binding and reactivity of Candida albicans estrogen binding protein with steroid and other substrates
27. Molecular analysis of CaMnt1p, a mannosyl transferase important for adhesion and virulence of Candida albicans
28. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole
29. Drug pumping mechanisms in Candida albicans
30. Molecular and phenotypic characterisation of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes
31. Translational regulation by ABC systems
32. Abc1: A new ABC transporter from the fission yeast Schizosaccharomyces pombe
33. The Schizosaccharomyces pombe mam 1 gene encodes an ABC transporter mediating secretion of M-factor
34. Correlation between Rhodamine 123 accumulation and azole sensitivity in Candida species: Possible role for drug efflux in drug resistance
35. Mutidrug resistance mediated by the ATP-binding cassette transporter protein MRP
36. Saccharomyces cerevisiae basicleucine zipper protein regulatory networks converge at the ATR1 structural gene
37. The multidrug resistance-associated protein (MRP) subfamily (Yrs1/Yor1) of Saccharomyces cerevisiae is important for the tolerance to a broad range of organic anions
38. Yeast gene YRR1, which is required for resistance to 4-nitroquinoline N-oxide, mediates transcriptional activation of the multidrug resistance transporter gene SNQ2
39. Steroid binding protein(s) in yeasts
40. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray
41. Complete inventory of the yeast ABC proteins
42. Solubilisation and characterisation of the overexpressed PDR5 multidrug resistance nucleotide triphosphatase of yeast
43. Identification and characterisation of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane
44. ATPase and multidrug transport activities of the overexpressed yeast ABC protein Yor1p
45. Multidrug resistance in Aspergillus nidulans involves novel ATP-binding cassette transporters
46. Fungal transporters involved in efflux of natural toxic compounds and fungicides
47. Positive autoregulation of the yeast transcription factor Pdr3p, which is involved in control of drug resistance
48. Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants
49. Peptides and ATP binding cassette peptide transporters
50. Mutations in the yeast PDR3, PDR4, PDR7 pleiotropic (multiple) drug resistance loci affect the transcript level of an ATP binding cassette transporter encoding gene, PDR5
51. Role of translocases in the generation of phosphatidylserine asymmetry
52. A novel ATP-binding cassette transporter involved in multidrug resistance in the filamentous fungus Aspergillus nidulans
53. Asymmetric distribution of phosphatidylethanolamine in C. albicans: Possible mediation by CDR1, a multidrug transporter belonging to ATP binding cassette (ABC) superfamily
54. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter
55. The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility
56. The Sge1 protein of Saccharomyces cerevisiae is a membrane associated multidrug transporter
57. Biosynthesis of cell walls of fungi
58. Multiple amino acid substitutions in lanosterol 14α-demethylase contribute to azole resistance in Candida albicans
59. An estrogen-binding protein and endogenous ligand in Saccharomyces cerevisiae: Possible hormone receptor system
60. Yap, a novel family of eight bZIP proteins in Saccharomyces cerevisiae with distinct biological functions
61. Analysis of the tangled relationships between P-glycoprotein-mediated mutlidrug resistance and the lipid phase of the cell membrane
62. Molecular mechanisms of chromosomal rearrangement in fungi
63. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate
64. Emerging novel antifungal agents
65. A fourth gene from the Candida albicans CDR family of ABC transporters
66. Antifungal agents: Mode of action, mechanism of resistance, and correlation of these mechanisms with bacterial resistance
67. Multidrug-resistant transport proteins in yeast: Complete inventory and phylogenetic characterisation of yeast open reading frames within the major facilitator superfamily
68. ABC transporters associated with cytochrome c biogenesis
69. Allelism of SNQ1 and ATR1, genes of the yeast Saccharomyces cerevisiae required for sensitivity to 4-nitroquinoline-N-oxide and aminotriazole
70. Yap1p, a yeast transcriptional activator that mediates multidrug resistance, regulates the metabolic stress response
71. Yeast glutathione reductase is required for protection against oxidative stress and is a target gene for yAP-1 transcriptional regulation
72. Identification of mutant alleles of CaMDR1, a major facilitator of Candida albicans which confers multidrug resistance and its in vitro transcriptional activation
73. Multiple signals from dysfunctional mitohondria activate the pleiotropic drug resistance pathway in Saccharomyces cerevisiae
74. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase
75. Mutagenesis of transmembrane domain 11 of P-glycoprotein by alanine scanning
76. Energy-dependent flip of fluorescent-labeled phospholipids is regulated by nutrient starvation and transcription factors, PDR1 and PDR3
77. Compounds active against cell walls of medically important fungi
78. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors
79. The SNQ3 gene of Saccharomyces cerevisiae confers hyper-resistance to several functionally unrelated chemicals
80. ABC transporters: Physiology, structure and mechanism - An overview
81. Saccharomyces cerevisiae YDR1, which encodes a member of the ATP-binding cassette (ABC) superfamily, is required for multidrug resistance
82. Resistance of Candida albicans to azole antifungal agents
83. The drug/metabolite transporter superfamily
84. Monosomy of a specific chromosome determines L-sorbose utilization: A novel regulatory mechanism in Candida albicans
85. The amiloride resistance gene, car1 of Schizosaccharomyces pombe
86. Diazoborine resistance in yeast involves the efflux pumps Ycf1p and Flr1p and is enhanced by a gain-of-function allele of gene YAP1
87. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site
88. ATR1, a Saccharomyces cerevisiae gene encoding a transmembrane protein required for aminotriazole resistance
89. Cytochromes P-450 of yeasts
90. Identification and expression of multidrug resistance-related ABC transporter gene in Candida krusei
91. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product
92. Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae
93. The yeast multidrug resistance pump, Pdr5p, confers reduced drug resistance in erg mutants of Saccharomyces cerevisiae
94. Benzo(a)pyrene hydroxylase activity in yeast is mediated by P450 other than sterol 14α-demethylase
95. Sterol 22-desaturase, cytochrome P45061, possesses activity in xenobiotic metabolism
96. 5,6-desaturation
97. The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity
98. Y132H substitution in Candida albicans sterol 14α-demethylase confers fluconazole resistance by preventing binding to haem
99. Active efflux by multidrug transporters as one of the strategies to evade chemotherapy and novel practical implications of yeast pleiotropic drug resistance
100. Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p
101. In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network
102. Efflux mediated resistance to fluconazole could be modulated by sterol homeostasis in Saccharomyces cerevisiae
103. LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones
104. Deletion of transmembrane domain 12 of CDR1, a multidrug transporter from Candida albicans, leads to altered drug specificity: Expression of a yeast multidrug transporter in Baculovirus expression system
105. Characterisation of human steroid hormone transport mediated by Cdr1p, multidrug transporter of Candida albicans, belonging to the ATP binding cassette super family
106. Expression of CDR1, a multidrug resistance gene of Candida albicans: In vitro transcriptional activation by heat shock, drugs and human steroid hormones
107. YAP1 dependent activation of TRX2 is essential for the response of Saccharomyces cerevisiae to oxidative stress by hyperoxides
108. The mutation T315A in Candida albicans sterol 14αdemethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity
109. 22- desaturase from the pathogenic fungus Candida glabrata
110. An ABC transporter in the mitochondrial inner membrane is required for normal growth of yeast
111. Molecular modelling of lanosterol 14αdemethylase (CYP51) from Saccharomyces cerevisiae via homology with CYP102, a unique bacterial cytochrome P450 isoform: Quantitative structure-activity relationships (QSARs) within two related series of antifungal azole derivatives
112. Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains
113. Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein
114. Inhibition of oxidative cross-linking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM 12 of human P-glycoprotein by drug substrates
115. Identification of residues in the drug binding domain of human P-glycoprotein
116. Molecular dissection of the human multidrug resistance P-glycoprotein
117. The transmembrane domains of the human multidrug resistance P-glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface
118. The packing of the transmembrane segments of human multidrug resistance P-glycoprotein is revealed by disulfide cross-linking analysis
119. The glyoxylate cycle is required for fungal virulence
120. The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: A novel target-for the transcription factors-Pdr1 and Pdr3
121. The ATP binding cassette transporters Pdr5 and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo
122. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport
123. Mechanisms of resistance to azole antifungal compounds
124. Molecular biological characterization of an azole-resistant Candida glabrata isolate
125. Contribution of mutations in the cytochrome P450 14α-demethylase (Erg 11p Cyp51p) to azole resistance in Candida albicans
126. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR
127. The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein
128. The role of ABC transporters in antibiotic-producing organisms: Drug secretion and resistance mechanisms
129. Interaction of the yeast pleitropic drug resistance genes PDR1 and PDR5
130. Sequence comparison of yeast ATP-binding cassette proteins
131. Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata
132. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis
133. The Skn7 response regulator controls gene expression in the oxidative stress response of the budding yeast Saccharomyces cerevisiae
134. Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination
135. Yeast YAP1 encodes a novel form of the Jun family of transcriptional activator protein
136. Chs 1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity
137. +, a novel gene of Schizosaccharomyces pombe which confers brefeldin A resistance, is structurally related to the ATP-binding cassette superfamily
138. A novel ATP-binding cassette transporter involved in multidrug resistance in the phytopathogenic fungus Penicillium digitatum
139. Multiple Yap1p-binding sites mediate induction of the yeast major facilitator FLR1 gene in response to drugs, oxidants, and alkylating agents
140. A leptomycin B resistance gene of Schizosaccharomyces pombe encodes a protein similar to the mammalian P-glycoproteins
141. Mating of the fission yeast independently of pmd1+ gene product, a structural homologue of budding yeast STE6 and mammalian P-glycoproteins
142. Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: Involvement of two hexose transporters
143. Role of ABC transporters in aureobasidin A resistance
144. CYP52 (cytochrome P450alk) multigene family in Candida maltosa: Identification and characterisation of eight members
145. Forty years of cytochrome P450
146. Heavy metal tolerance in the fission yeast requires an ATP-binding cassette-type vacuolar membrane transporter
147. YAP1 confers resistance to the fatty acid synthase inhibitor cerulenin through the transporter Flr1p in Saccharomyces cerevisiae
148. CaALK8, an alkane assimilating cytochrome P450 confers multiple drug resistance when expressed in a hypersensitive strain of Candida albicans
149. Major facilitator superfamily
150. Proton-dependent multidrug efflux systems
151. Specific chromosome alterations in fluconazole-resistant mutants of Candida albicans
152. The Pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast
153. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors
154. Molecular cloning and characterisation of a novel gene of C. albicans, CDR1, conferring multiple resistance to drugs and antifungals
155. Multidrug resistance: An emerging threat
156. A Ste6p/P-glycoprotein homologue from the asexual yeast Candida albicans transports the a-factor mating pheromone in Saccharomyces cerevisiae
157. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
158. A functional-phylogenetic classification system for transmembrane solute transporters
159. Families and superfamilies of transport proteins common to prokaryotes and eukaryotes
160. Evolutionary origins of multidrug and drug-specific efflux pumps
161. Protein synthesis in yeast: Structural and functional analysis of the gene encoding elongation factor 3
162. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
163. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterisation of CDR2, a new multidrug ABC transporter gene
164. Amino acid substitutions in the cytochrome P-450 lanosterol 14-α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungals
165. Multiple resistance mechanism to azole antifungals in yeast clinical isolates
166. The role of the ATP binding cassette (ABC)-transporter genes CgCDR1 and CgCDR2 in the resistance of Candida glabrata to azole antifungals
167. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents
168. Analysis of the ATP-binding cassette (ABC)-transporter gene CDR4 from Candida albicans
169. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata
170. Cloning and analysis of a Candida maltosa gene which confers resistance to cycloheximide
171. ABC transporters catalyzing carbohydrate uptake
172. Identification and characterisation of additional members of the cytochrome P450 multigene family CYP52 of Candida tropicalis
173. Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases
174. PXA1, a possible Saccharomyces cerevisiae ortholog of the human adrenoleukodystrophy gene
175. Characterisation and analysis of conserved motifs in a peroxisomal ATP-binding cassette transporter
176. Characterisation of an estrogen-binding protein in the yeast Candida albicans
177. Induced expression of a novel Aspergillus fumigatus putative drug efflux gene in response to itraconazole
178. Hormonal and environmental regulation of a plant PDR5-like ABC transporter
179. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators
180. Membrane transporters and antifungal drug resistance
181. Gene amplification
182. Ketoconazole binds to the intracellular corticosteroid-binding protein in Candida albicans
183. A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein
184. Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease
185. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae
186. Molecular characterization of a new ATP-dependent transporter in Candida albicans
187. Plant ABC transporters
188. Cloning and characterisation of CneMDR1: A Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins
189. Multiple functions of Pmt1p-mediated protein O-mannosylation in the fungal pathogen Candida albicans
190. Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus
191. Differential expression of genes coding for ABC transporters after treatment of Arabidoposis thaliana with xenobiotics
192. Human P-glycoprotein transports cortisol, aldosterone and dexamethasone, but not progesterone
193. How does P-glycoprotein recognize its substrates?
194. Recent progress in P-glycoprotein research
195. An ATP-driven efflux pump is a novel pathogenicity factor in rice blast disease
196. PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs
197. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
198. Multidrug transporters from bacteria to man: Similarities in structure and function
199. Cytochromes P450 in fungi
200. Biochemical approaches to selective antifungal activity, focus on azole antifungals
201. Characterization of an azole resistant Candida glabrata isolate
202. Mechanisms and clinical impact of antifungal drug resistance
203. GCN20, a novel ABC protein and GCN1 reside in a complex that mediates activation of the elF-2 kinase GCN2 in amino acid starved cells
204. Distantly related sequences in the α- and β-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold
205. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: Implications for antifungal azole resistance
206. Diazoborine resistance in the yeast Saccharomyces cerevisiae reveals a link between YAP1 and the pleitropic drug resistance genes PDR1 and PDR3
207. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increased azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
208. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α demethylase in Candida albicans
209. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient
210. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
211. Imidazole derivatives - A new class of microsomal enzyme inhibitors
212. Substituted imidazoles as inhibitors of microsomal oxidation and insecticide synergists
213. Activation of the multidrug resistance gene MDR1 in fluconazole resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor
214. The yeast ATP binding cassette (ABC) protein genes PDR10 and PDR15 are novel targets for the Pdr1 and Pdr3 transcriptional regulators
215. Fungal ABC proteins: Pleiotropic drug resistance, stress response and cellular detoxification
216. GSH1, which encodes γ-glutamylcysteine synthetase, is a target gene for yAP-1 transcriptional regulation
217. Crm1p mediates regulated nuclear export of a yeast AP-1-like transcription factor
218. Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1
219. Crosstalk between transcriptional regulators of multidrug resistance in Saccharomyces cerevisiae
220. Oestrogen-binding protein in Candida albicans: Antibody development and cellular localisation by electron immunocytochemistry